This paper reviews several research-based treatments for rosacea, a chronic skin condition characterized by facial redness, lesions, and swelling. Drawing on four peer-reviewed studies, the paper examines intense pulsed light therapy, topical treatments including pimecrolimus cream and kinetin lotion, and oral zinc sulfate supplementation. Each treatment is evaluated for its efficacy and patient tolerability. The paper concludes that because rosacea patients respond differently to various interventions, a range of treatment options remains important — allowing clinicians to match therapy to individual patient needs in the absence of a definitive cure.
The paper demonstrates basic literature synthesis: rather than simply listing studies, it presents each one as evidence contributing to a cumulative argument — that no single treatment works for all rosacea patients. Each paragraph connects its cited study back to the paper's central claim, modeling how to use sources as support rather than as stand-alone summaries.
The paper opens with a brief definition of rosacea and the problem of having no cure, then devotes one body paragraph to each of four distinct treatments drawn from peer-reviewed studies. The conclusion synthesizes the findings by emphasizing patient variability. This structure — introduction, evidence paragraphs by treatment type, synthesis conclusion — is a clear example of a short comparative research review suitable for undergraduate coursework.
Rosacea is a medical condition characterized by reddening of the skin, primarily affecting the face. Sores may appear on the skin, and the face may also swell to some degree. It is an unfortunate condition in which patients must cope not only with the physical symptoms but also with psychological consequences stemming from feeling unattractive due to skin discoloration and lesions. Although there is currently no cure for rosacea, scientists have researched various treatments to help patients suffering from the condition.
In the article "Treatment of Rosacea with Intense Pulsed Light," researchers Papageorgiou et al. considered how ultraviolet and pulsed light might positively treat skin conditions like rosacea. During this experiment, the researchers tested 34 patients who received treatments every three weeks over a total of twelve weeks. More than 70% of patients experienced at least a 50% reduction in skin abnormalities after the final treatment (Papageorgiou 632). Remarkably, the results were still observed months after the experiment concluded. This has significant implications because it suggests that intense pulsed light therapy may prove to be among the most effective treatments for rosacea, and could potentially point toward an eventual cure.
Other researchers have advocated the use of topical creams for the treatment of rosacea. In "Pimecrolimus 1% Cream for the Treatment of Steroid-Induced Rosacea," Lee and colleagues suggested that pimecrolimus could be used to treat rosacea linked to steroid use. Steroids, whether used with or without a prescription, have been associated with several side effects, including pronounced skin problems. Each patient in the study was asked to apply the cream to one side of their face while leaving the other side untreated. Most patients showed a visible change in appearance after only a single week of treatment. By the fourth week of the eight-week study, some patients no longer showed any sign of rosacea on the cream-treated side of their face (Lee 1076). This indicates that rosacea in steroid-using patients can be effectively treated with this cream, though further experimentation is needed regarding other forms of rosacea and the cream's broader effectiveness.
Research has revealed a wide range of methods for treating rosacea. Just as no two diseases are the same, no two patients are the same. Some individuals will respond better to topical creams, others to light therapy, and still others to oral supplementation. Each treatment discussed has been shown to provide relief for certain rosacea patients, and therefore all remain viable options for clinicians and patients to consider.
You’re 54% through this paper. Sign up to read the remaining 2 sections.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.